Home > Press > New Hampshire Urges Significant Changes to the Patent Reform Act of 2007
Abstract:
Signatories Raise Concerns Over Job Growth and Future of State's Innovation Economy
AmberWave Systems, along with five other New Hampshire-based organizations and more than 200 signers nationally, contacted key members of the House and Senate Judiciary Committees this week expressing a united opposition against three problematic elements of the Patent Reform Act of 2007.
In addition to AmberWave, the New Hampshire-based signatories included the New Hampshire Department of Recourses and Economic Development (DRED); Dartmouth Regional Technology Center in Lebanon; the New Hampshire Biotechnology Council in Portsmouth; the University of New Hampshire in Durham; and SmoothShapes, Inc. in Merrimack.
The New Hampshire contingent was unique among the 200 signers. New Hampshire's state government's economic development agency, it's leading state university, a leading technology development center, a high-tech trade organization, and multiple start-up companies each signed the letter.
"New Hampshire is taking a national lead on this issue," said Bryan Lord, vice president of finance & licensing and general counsel for AmberWave Systems. "Our technology businesses, university leaders and state government all understand the importance of innovation and strong patent protection to the future of our state's economy, job growth, and quality of life. As currently drafted, the proposed legislation undermines the innovation engine upon which the future of our state and region depends."
The letter states that the Patent Reform Act will, "hinder innovation across the diverse sectors of the American economy we represent, including academia, agriculture, alternative energy, biotechnology, chemicals, electronics, environmental technology, financial services, information technology, life sciences, manufacturing, nanotechnology and telecommunications." The letter then states three shared areas of concern and recommends striking the Act's provisions most likely to damage the innovation economy:
* Language pertaining to the apportionment of damages;
* The creation of an open-ended post-grant review process;
* The granting of unprecedented rulemaking authority for the Patent and Trademark Office.
Additionally, the letter calls for modifications to provisions in the bill that would establish a first-to-file system of priority.
AmberWave Systems is a founding member of The Innovation Alliance, a coalition of entrepreneurial companies who also co-signed the letter and is seeking to enhance America's innovation environment by improving the quality of patents granted and protecting the integrity of the U.S. patent system. A copy of the letter can be found at
http://www.innovationalliance.net/media_center/news/Patent200LetterFinal.pdf .
####
About AmberWave Systems
Founded in 1998, AmberWave Systems has become a leader in the research, development and licensing of advanced technologies for semiconductor manufacturing. By funding and guiding university research, AmberWave Systems is bringing new technology developments to fruition through patents and technology licensing. In conjunction with its university research projects, AmberWave Systems conducts its own research, development and limited manufacturing in its semiconductor fabrication facility in Salem, New Hampshire. In addition, AmberWave Systems collaborates with other technology focused companies to further expand and develop its research.
For more information, please click here
Contacts:
Shelton Group
Melissa Conger, 972-239-4559 ext. 137
Copyright © Business Wire 2007
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Jobs
Could quantum technology be New Mexico’s next economic boon? Quantum New Mexico Coalition aims to establish state as national hub April 1st, 2022
SEMI Partners with GLOBALFOUNDRIES to Offer Apprenticeship Program Aimed at Building the Electronics Talent Pipeline August 11th, 2020
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Marketplace Rule 5635(c)(4) March 29th, 2019
Govt.-Legislation/Regulation/Funding/Policy
New discovery aims to improve the design of microelectronic devices September 13th, 2024
Physicists unlock the secret of elusive quantum negative entanglement entropy using simple classical hardware August 16th, 2024
Single atoms show their true color July 5th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||